Direkt zum Inhalt

Bogdahn, Ulrich ; Hau, Peter ; Stockhammer, G. ; Venkataramana, N. K. ; Mahapatra, A. K. ; Suri, A. ; Balasubramaniam, A. ; Nair, S. ; Oliushine, V. ; Parfenov, V. ; Poverennova, I. ; Zaaroor, M. ; Jachimczak, P. ; Ludwig, S. ; Schmaus, S. ; Heinrichs, H. ; Schlingensiepen, K. H.

Targeted therapy for high-grade glioma with the TGF-β2 inhibitor trabedersen: results of a randomized and controlled phase IIb study

Article

Bogdahn, Ulrich, Hau, Peter, Stockhammer, G., Venkataramana, N. K., Mahapatra, A. K., Suri, A., Balasubramaniam, A., Nair, S., Oliushine, V., Parfenov, V., Poverennova, I., Zaaroor, M., Jachimczak, P., Ludwig, S., Schmaus, S., Heinrichs, H. and Schlingensiepen, K. H. (2011) Targeted therapy for high-grade glioma with the TGF-β2 inhibitor trabedersen: results of a randomized and controlled phase IIb study. Neuro-oncology 13 (1), pp. 132-142.



Involved Institutions


Details

Item typeArticle
Journal or Publication TitleNeuro-oncology
PublisherOXFORD UNIV PRESS INC
Place of PublicationCARY
Volume13
Number of Issue or Book Chapter1
Page Rangepp. 132-142
Date2011
Date of publication09 Dec 2013 11:08
Additional Information (public)Trabedersen Glioma Study Group
InstitutionsMedicine > Lehrstuhl für Neurologie
Identification Number
ValueType
21558078PubMed ID
10.1093/neuonc/noq142DOI
Classification
NotationType
AdultMESH
Antineoplastic Agents/therapeutic useMESH
Brain Neoplasms/pathologyMESH
FemaleMESH
Glioblastoma/pathologyMESH
HumansMESH
International AgenciesMESH
MaleMESH
Middle AgedMESH
Neoplasm Recurrence, Local/pathologyMESH
Oligodeoxyribonucleotides/therapeutic useMESH
Survival RateMESH
Thionucleotides/therapeutic useMESH
Transforming Growth Factor beta2/antagonists & inhibitorsMESH
Treatment OutcomeMESH
KeywordsRECURRENT MALIGNANT GLIOMA; GROWTH-FACTOR BETA-2; PROGNOSTIC-FACTORS; BRAIN-TUMORS; ADJUVANT TEMOZOLOMIDE; CLINICAL-TRIALS; TGF-BETA; GLIOBLASTOMA; IMMUNOSUPPRESSION; CONCOMITANT; anaplastic astrocytoma; antisense oligonucleotide; convection-enhanced delivery; glioblastoma multiforme; recurrent or refractory high-grade glioma; targeted therapy; temozolomide; trabedersen; transforming growth factor beta 2
Dewey Decimal Classification600 Technology > 610 Medical sciences Medicine
StatusPublished
RefereedYes, this version has been refereed
Created at the University of RegensburgUnknown
Item ID29178

Export bibliographical data

Owner only: item control page

nach oben